The total output value of Tibetan medicine in our region exceeds 1.3 billion yuan.

Release time:

2015-12-19 10:22

　　The total output value of Tibetan medicine in Tibet has exceeded 1.3 billion yuan, and a number of Tibetan medicine enterprises have gradually grown into sizable entities. The Tibetan medicine system is now basically established, and some Tibetan medicines have begun to spread beyond the plateau, gaining popularity among patients in mainland China.

　　Tibetan medicine is currently one of the most comprehensive and influential ethnic medicines in China. In recent years, Tibet has proposed a holistic approach driven by broad vision and strategic thinking to propel the Tibetan medicine sector toward leapfrog development—particularly by leveraging market forces to formulate industrial plans for Tibetan medicines, adjust and optimize the industrial layout, vigorously guide Tibetan medicine enterprises in their transformation and upgrading, improve the investment and financing environment for these enterprises, and foster the vigorous growth of the Tibetan medicine industry, thereby giving rise to a number of Tibetan medicine enterprises that are gradually scaling up.

　　The reporter learned from the Health and Family Planning Commission of the Tibet Autonomous Region that there are currently 18 Tibetan medicine manufacturers across Tibet, all of which have been certified by the national GMP (Good Manufacturing Practice for Pharmaceuticals). Among them are listed Tibetan medicine companies such as Qizheng Tibetan Medicine and Tibet Pharmaceutical.

　　Nima Ciren, the dean of the Tibet Tibetan Medical College, said that most of the medicines used in Tibetan medicine are sourced from high-altitude regions characterized by extreme temperature differences and intense sunlight. Tibetan medicinal formulations primarily consist of herbal plants and have shown promising efficacy in treating certain complex and difficult-to-cure diseases.

　　Thanks to this, Tibetan medicine is gradually gaining popularity among patients from mainland China. At the Xueyu Pharmacy in Lhasa, the reporter observed that many tourists were purchasing products such as Zhenzhu Qishiyi Pills for treating cerebral infarction and Qizheng Xiaotong Plaster for rheumatoid arthritis. Shopkeeper Ma Shaobu said, “In recent years, the number of tourists visiting Tibet has been increasing, and more and more people from mainland China are coming to buy Tibetan medicines. Mainland Chinese buyers now account for 15% to 20% of our customers.”

　　Reporting media: Tibet Daily

　　Report link: http://epaper.chinatibetnews.com/xzrb/html/2015-12/19/content_665107.htm

Qizheng Tibetan Medicine was invited to speak.

62 companies have been listed on the “Golden Bee 2015 Outstanding Corporate Social Responsibility Report List.”